SCHEMBL8057804

SCHEMBL8057804

CC(C)COC[C@H]1O[C@@H](n2cnc3c(=O)[nH]c(N)nc32)C[C@@H]1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.65
P2RY2 P41231 1/20 0.55
P2RY4 P51582 1/20 0.55
P2RY6 Q15077 1/20 0.55
HINT1 P49773 3/20 0.49
TYMP P19971 1/20 0.49
NT5E P21589 2/20 0.47
POLA1 P09884 1/20 0.46
PNP P00491 1/20 0.46
LMNA P02545 1/20 0.46
TP53 P04637 1/20 0.46
HTT P42858 1/20 0.46
PDE4D Q08499 1/20 0.46
PDE3A Q14432 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46
FUT5 Q11128 1/20 0.45
GSK3A P49840 2/20 0.44
RPS6KA3 P51812 2/20 0.44
MAPK14 Q16539 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3744960 0.90 POLB (0.68) POLBP2RY2P2RY4P2RY6HINT1
SCHEMBL3751858 0.89 POLB (0.67) POLBP2RY2P2RY4P2RY6HINT1
SCHEMBL338650 0.88 POLB (0.70) POLBP2RY2P2RY4P2RY6HINT1
SCHEMBL16359949 0.88 POLB (0.70) POLBP2RY2P2RY4P2RY6HINT1
SCHEMBL367384 0.87 POLB (0.65) POLBP2RY2P2RY4P2RY6HINT1
SCHEMBL8490891 0.87 POLB (0.71) POLBP2RY2P2RY4P2RY6HINT1
SCHEMBL442294 0.87 POLB (0.71) POLBP2RY2P2RY4P2RY6HINT1
SCHEMBL8786909 0.86 POLB (0.60) POLBP2RY2P2RY4P2RY6HINT1
SCHEMBL15798769 0.86 POLB (0.70) POLBP2RY2P2RY4P2RY6HINT1
SCHEMBL15012843 0.86 POLB (0.70) POLBP2RY2P2RY4P2RY6HINT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0767842-B1 METHODS OF SCREENING FOR NUCLEOSIDE ANALOGS THAT ARE INCORPORATED BY HIV REVERSE TRANSCRIPTASE AND CAUSE INCORRECT BASE PAIRING UNIV WASHINGTON (US) 2000-09-27 EP claimed
EP-1004675-A2 Methods of screening for nucleoside analogs that are incorporated by HIV reverse transcriptase and cause incorrect base pairing DARWIN MOLECULAR CORPORATION (US) 2000-05-31 EP claimed
EP-0548189-B1 A METHOD OF LINKING NUCLEOSIDES WITH A SILOXANE BRIDGE STERLING WINTHROP INC (US) 1994-12-28 EP claimed
EP-0548189-A1 A METHOD OF LINKING NUCLEOSIDES WITH A SILOXANE BRIDGE. STERLING WINTHROP INC (US) 1993-06-30 EP claimed
WO-1992004364-A1 A METHOD OF LINKING NUCLEOSIDES WITH A SILOXANE BRIDGE STERLING WINTHROP INC. (US) 1992-03-19 WO claimed
EP-0767842-B1 METHODS OF SCREENING FOR NUCLEOSIDE ANALOGS THAT ARE INCORPORATED BY HIV REVERSE TRANSCRIPTASE AND CAUSE INCORRECT BASE PAIRING UNIV WASHINGTON (US) 2000-09-27 EP disclosed
EP-1004675-A2 Methods of screening for nucleoside analogs that are incorporated by HIV reverse transcriptase and cause incorrect base pairing DARWIN MOLECULAR CORPORATION (US) 2000-05-31 EP disclosed
EP-0548189-B1 A METHOD OF LINKING NUCLEOSIDES WITH A SILOXANE BRIDGE STERLING WINTHROP INC (US) 1994-12-28 EP disclosed
WO-1992004364-A1 A METHOD OF LINKING NUCLEOSIDES WITH A SILOXANE BRIDGE STERLING WINTHROP INC. (US) 1992-03-19 WO disclosed
EP-0083777-B1 PHYSIOLOGICALLY ACTIVE PEPTIDE WITH BETWEEN 147 AND 162 AMINO ACID RESIDUES Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1986-07-23 EP disclosed